Non-Hodgkin's Lymphoma (NHL)
Also known as: NonHodgkin Lymphoma / Lymphoma (Non-Hodgkin's Lymphoma) / Lymphoma, Nonhodgkin / Lymphoma Nonhodgkin / Non Hodgkin´s Lymphomas / NHL / Lymphomas: Non-Hodgkin / Lymphoma, Non-Hodgkin (NHL) / NHL - Non-Hodgkin's Lymphoma / NHL (Non-Hodgkin Lymphoma) / Lymphoma,Non-Hodgkin / Non-Hodgkin's Disease / Lymphoma, Non-Hodgkin;Hodgkin Disease / Non Hodgkin Lymphoma / Non Hodgkin's Lymphoma / Lymphoma, Non Hodgkin / Non Hodgkin Lymphoma (NHL) / Non-Hodgkin / Non-Hodgkin's Lymphomas / Non-Hodgkin Lymphoma / Non-Hodgkin Lympoma / Non-Hodgkins Lymphoma (NHL) / Non-Hodgkin-Lymphoma / Lymphoma, Non-Hodgkin's / Non Hodgkins Lymphoma / Non-Hodgkin Lymphomas / Lymphoma, Non-Hodgkin / Non-Hodgkin's Lymphoma(NHL) / Lymphoma. Non-Hodgkin / Non-Hodgkin's Lymphoma / Non-Hodgkins Lymphoma / Lymphoma Non-Hodgkin / Non-Hodgkins's Lymphoma / Non-Hodgkin’s lymphoma / Lymphoma, Non-Hodgkins / Non-Hodgkins / Non-Hodgkin Lymphoma (NHL) / Non-Hodgkin's Lymphoma or Hodgkin's Disease / Centrocytic lymphoma / Lymphoma NOS / (Non-Hodgkin's lymphoma) or (histiocytosis X) or (Letterer-Siwe disease) or (lymphatic tissue Ca NOS) / [X]Non-Hodgkin's lymphoma, unspecified type (disorder) / Non-Hodgkin's lymphoma NOS / Malignant lymphoma - small cleaved cell (disorder) / Non-Hodgkin's lymphoma (disorder) / Non-Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality) / [M]Malignant lymphoma, small cleaved cell, diffuse (morphologic abnormality) / [X]Non-Hodgkin's lymphoma, unspecified type / Non-Hodgkin lymphoma - category (morphologic abnormality) / Lymphoma (non-Hodgkin's) / Malignant lymphoma, small cleaved cell, diffuse -RETIRED-
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00290 | Bleomycin | A chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others. |
| DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
| DB00242 | Cladribine | A purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs. |
| DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
| DB00987 | Cytarabine | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. |
| DB00694 | Daunorubicin | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. |
| DB00773 | Etoposide | A podophyllotoxin derivative used to treat testicular and small cell lung tumors. |
| DB01181 | Ifosfamide | An alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteocarcinoma, bladder cancer, small cell lung cancer, and non-Hodgkin's lymphoma. |
| DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |
| DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
| DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
| DB01168 | Procarbazine | An antineoplastic agent indicated for the treatment of stage III and stage IV Hodgkin's disease in combination with other chemotherapeutic agents. |
| DB00541 | Vincristine | A vinca alkaloid used to treat acute leukemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, and acute panmyelosis. |